Mechanisms of antibiotic resistance in Burkholderia pseudomallei: implications for treatment of melioidosis.
about
Glycosyltransferases and Transpeptidases/Penicillin-Binding Proteins: Valuable Targets for New AntibacterialsGenomic characterization of Burkholderia pseudomallei isolates selected for medical countermeasures testing: comparative genomics associated with differential virulenceImmune Modulation as an Effective Adjunct Post-exposure Therapeutic for B. pseudomalleiSusceptibility of Select Agents to Predation by Predatory BacteriaIncreased Von Willebrand factor, decreased ADAMTS13 and thrombocytopenia in melioidosis.Within-Host Evolution of Burkholderia pseudomallei during Chronic Infection of Seven Australasian Cystic Fibrosis Patients.In Vitro and In Vivo Activity of Omadacycline against Two Biothreat Pathogens, Bacillus anthracis and Yersinia pestis.Melioidosis: Clinical impact and public health threat in the tropics.PKC-η-MARCKS Signaling Promotes Intracellular Survival of Unopsonized Burkholderia thailandensisAn avirulent Burkholderia pseudomallei ∆purM strain with atypical type B LPS: expansion of the toolkit for biosafe studies of melioidosis.New insights from the 7th World Melioidosis Congress 2013.Demonstrating the Protective Efficacy of the Novel Fluoroquinolone Finafloxacin against an Inhalational Exposure to Burkholderia pseudomallei.Rapid Burkholderia pseudomallei identification and antibiotic resistance determination by bacteriophage amplification and MALDI-TOF MS.The chemical arsenal of Burkholderia pseudomallei is essential for pathogenicity.Interaction of Interferon gamma-induced reactive oxygen species with ceftazidime leads to synergistic killing of intracellular Burkholderia pseudomallei.Treatment and prophylaxis of melioidosisCrystallization and preliminary crystallographic studies of the hypothetical protein BPSL1038 from Burkholderia pseudomallei.Septicaemic melioidosis: case report from a non-endemic area.Whole-genome sequence of Chryseobacterium oranimense, a colistin-resistant bacterium isolated from a cystic fibrosis patient in France.Substituted diphenyl ethers as a novel chemotherapeutic platform against Burkholderia pseudomallei.Interplay between three RND efflux pumps in doxycycline-selected strains of Burkholderia thailandensisEfflux pump-mediated drug resistance in Burkholderia.Using Amplicon Sequencing To Characterize and Monitor Bacterial Diversity in Drinking Water Distribution SystemsSnake Cathelicidin NA-CATH and Smaller Helical Antimicrobial Peptides Are Effective against Burkholderia thailandensisTriggering Receptor Expressed on Myeloid Cells (TREM)-2 Impairs Host Defense in Experimental MelioidosisTwo-Phase Bactericidal Mechanism of Silver Nanoparticles against Burkholderia pseudomallei.Transient In Vivo Resistance Mechanisms of Burkholderia pseudomallei to Ceftazidime and Molecular Markers for Monitoring Treatment Response.The gut microbiota as a modulator of innate immunity during melioidosisExposing a β-Lactamase "Twist": the Mechanistic Basis for the High Level of Ceftazidime Resistance in the C69F Variant of the Burkholderia pseudomallei PenI β-Lactamase.A Structure-Based Classification of Class A β-Lactamases, a Broadly Diverse Family of Enzymes.Membrane-Bound PenA β-Lactamase of Burkholderia pseudomalleiNematode Peptides with Host-Directed Anti-inflammatory Activity Rescue Caenorhabditis elegans from a Burkholderia pseudomallei Infection.In vitro activities of amoxicillin-clavulanate, doxycycline, ceftazidime, imipenem, and trimethoprim-sulfamethoxazole against biofilm of Brazilian strains of Burkholderia pseudomalleiTherapeutic Administration of a Monoclonal Anti-Il-1β Antibody Protects Against Experimental Melioidosis.Correlates of immune protection following cutaneous immunization with an attenuated Burkholderia pseudomallei vaccine.Antimicrobial activity of Tachyplesin 1 against Burkholderia pseudomallei: an in vitro and in silico approach.Discovery of Inhibitors of Burkholderia pseudomallei Methionine Aminopeptidase with Antibacterial Activity.The Burkholderia pseudomallei enoyl-acyl carrier protein reductase FabI1 is essential for in vivo growth and is the target of a novel chemotherapeutic with efficacy.Melioidosis: molecular aspects of pathogenesis.Multidrug efflux pumps in Gram-negative bacteria and their role in antibiotic resistance.
P2860
Q26749531-CF009A9B-65F7-4D42-9A20-65FA8365ADD8Q28544928-13E2854B-BDEC-4B3A-B7A0-B3D220352F94Q28553046-7D4CC9F4-B5D7-496B-BFEA-5DBF9A98C4A5Q28830255-F6FE0CFB-38F7-4110-8899-5D4AB0A473C1Q33440172-B0B27352-0E2B-4A0A-A069-47C262EA7C0AQ33555304-2607284C-1A42-45F7-BAED-397FA9B8684DQ33601803-E20AEC63-9586-46AF-BB9E-45B37A082E7FQ33663333-CD1B4FB5-7579-4E20-AD0F-E667622F46B4Q33770513-B7F9EDA5-A129-4A0E-8AD8-87F36F7A792FQ33771536-370722C2-E918-4D7C-9C1D-429AE2F0AA13Q33816438-CC48944B-947A-40FD-A069-2D1C7789A361Q33843665-2A4FD5E1-6EB8-42B7-A95E-33352CCD176AQ33877994-CCAB307A-896F-4598-A1AF-B3252ADC3899Q33879176-803F016A-930D-43AB-87D0-8823C091C754Q34299155-CEB97290-2954-4474-973A-E9BC7EAE08A7Q34538191-A93BDBFB-1437-46C7-AD20-BE1DBF51BAF6Q34652986-6A754120-E5A1-47E4-A74E-CFFDC76FD47DQ35046324-CECD7068-4DCB-4AC0-961C-D79360A53CBDQ35076797-BE9201E5-34ED-494D-97CB-39D5A48EACE4Q35079030-C3760984-29E7-4612-A462-75E98A7B1D71Q35080818-75FCB6C4-FFDC-4B00-8A58-CE042A79E021Q35407877-99EAFA10-BA74-49E1-AB1A-85F429D1FEFEQ35688506-06285D7D-956C-4CFB-AFFF-25356835E065Q35702275-50622A50-B2ED-48F7-B751-DA555F40B221Q36037861-11ACC372-F8D8-452D-91E2-DD5675A99BD3Q36224990-451EEFB0-02D3-4423-B3E7-541FCAA6CCFBQ36247396-7B5878BD-E12F-4A02-AB1A-725C0633DA9BQ36350799-8B7D0E09-B902-447E-9034-9C5B9B3892E7Q36571985-E7D58B1E-4063-4CC4-9094-7EC64052B9DEQ36630989-E3A379A3-394E-4001-A4A3-314EA807A1BAQ36644825-FEAA3814-9EFF-4C31-ADB3-39ABC23FC2B6Q37248305-F34A4C55-4E91-496A-A043-64ACCDF9EC3CQ37263509-10CB4FFC-97A6-408A-9C1B-8DC90B57D41DQ37327336-ACFEBCD5-2CBC-46C8-A027-3B8D83E57555Q37336008-512EC71D-FE54-4CD7-BFD9-CC2A16548A00Q37383388-4FD741D1-D705-4C80-AD8E-93AE1E5819EAQ37410489-E2866647-B10D-41BB-A0AA-A85C3ADCDED2Q37544698-55C97F36-CC96-48EC-824C-EC688D13C238Q38259874-625202EA-ED11-44DE-BFFF-46C06BA3CE56Q38269145-2A1327B0-4CDE-4714-A831-1DFE1E324F6A
P2860
Mechanisms of antibiotic resistance in Burkholderia pseudomallei: implications for treatment of melioidosis.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Mechanisms of antibiotic resis ...... for treatment of melioidosis.
@en
type
label
Mechanisms of antibiotic resis ...... for treatment of melioidosis.
@en
prefLabel
Mechanisms of antibiotic resis ...... for treatment of melioidosis.
@en
P2860
P921
P356
P1433
P1476
Mechanisms of antibiotic resis ...... for treatment of melioidosis.
@en
P2093
Herbert P Schweizer
P2860
P304
P356
10.2217/FMB.12.116
P577
2012-12-01T00:00:00Z